Clinical Trial

Metabolic Complications Using a Low- Versus High Concentration Citrate Solution for Regional Anticoagulation in Continuous Kidney Replacement Therapy: A Pragmatic Randomized Trial

Study acronym: LEON1
Completed
View on ClinicalTrials.gov →
Summary
This study is a pragmatic, randomized trial comparing two commercially available citrate solutions to determine their impact on metabolic complications in critically ill patients with acute kidney injury receiving continuous kidney replacement therapy with regional citrate anticoagulation.
Trial Details
NCT Number NCT07751861
Lead Sponsor University Hospital, Antwerp
Conditions Acute Kidney Injury
Enrollment 176 participants
Start Date 2023-10-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-07